Subscribe to Newsletter

Marc Martinell

The Power List 2021 – Advanced Medicine

Co-Founder & Chief Executive Officer at Minoryx

Marc co-founded Minoryx to provide therapeutic options to patients of orphan diseases with no alternatives. The company recently presented results from its phase II/III ADVANCE study, showing that leriglitazone reduced progression of cerebral lesions and myelopathy symptoms in adrenomyeloneuropathy patients. Martinell has previously worked for Crystax Pharmaceuticals and Oryzon Genomics, where he managed several research projects and led the team in charge of target selection, structural biology, computational chemistry, and hit ID through a fragment-based approach. According to Martinell, the biggest challenge the industry faces this year is uncertainty.

Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine